Baxter International Inc.

NYSE:BAX

Medical - Instruments & Supplies

Healthcare
$26.16 -5.23%

-$1.07 today

Market cap
$13.53B
Beta
0.64
P/E (TTM)
-9.1
EPS (TTM)
-$2.13
Dividend yield
1.03%
52W Low $15.73High $31.76

Volume 4.01M

Average 7.62M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$845.00M

FY 2025 · Annual

-17.1% YoY

Investing Cash Flow

$2.84B

FY 2025 · Annual

Financing Cash Flow

-$4.22B

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.03B(3.11B)181M(326M)(957M)
Depreciation & Amortization867M1.07B984M997M981M
Deferred Income Tax(161M)(260M)(256M)(262M)77M
Stock-Based Compensation146M140M115M114M117M
Change in Working Capital(57M)(606M)161M(236M)(108M)
Accounts Receivables(170M)(48M)(38M)(35M)(132M)
Inventory(27M)(198M)(128M)(201M)(119M)
Accounts Payables105M(67M)92M112M3M
Other Working Capital35M(293M)235M(112M)140M
Other Non-Cash Items394M3.98B541M732M735M
Operating Cash Flow2.22B1.21B1.73B1.02B845M
Capital Expenditures(691M)(635M)(436M)(460M)(522M)
Acquisitions (Net)(10.5B)(263M)(6M)00
Purchases of Investments00000
Sales of Investments00034M0
Other Investing Activities(7M)(33M)3.66B(200M)3.35B
Investing Cash Flow(11.2B)(931M)3.21B(626M)2.84B
Debt Repayment9.33B(899M)(2.94B)(531M)(3.79B)
Common Stock Issued187M127M95M71M30M
Common Stock Repurchased(600M)(32M)000
Dividends Paid(530M)(573M)(586M)(590M)(348M)
Other Financing Activities(138M)(61M)(63M)(31M)(107M)
Financing Cash Flow8.25B(1.44B)(3.49B)(1.08B)(4.22B)
Effect of Forex Changes(47M)(76M)26M(96M)84M
Net Change in Cash(780M)(1.23B)1.48B(784M)(446M)
Free Cash Flow1.53B576M1.29B559M323M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$957.0M
+ D&A$981.0M
+ Stock-Based Comp$117.0M
+ Deferred Tax$77.0M
- Working Capital-$108.0M
+ Other Non-Cash$735.0M
= Operating Cash Flow$845.0M
- Capex-$522.0M
= Free Cash Flow$323.0M

Analysis

FY2025 free cash flow is $323.0M. FCF conversion is -33.8% of net income. Operating cash flow was $845.0M, with capex of -$522.0M. The largest bridge item is D&A at $981.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 29, 2026
10-QQuarterly reportOct 29, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
3Initial statement of beneficial ownershipOct 2, 2026
3Initial statement of beneficial ownershipSep 18, 2026

Does BAX generate free cash flow?

Baxter International Inc. (BAX) generated $323.00M of free cash flow in fiscal 2025.

How much operating cash flow does BAX produce?

Operating cash flow was $845.00M, before capital expenditures of $522.00M.